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ABSTRACT Neal and Cunningham (Neal, M. J., and J. R. Cunningham. 1995. J. Physiol. (Lond.). 482:363–372) showed that
GABAB agonists and glycinergic antagonists enhance the light-evoked release of retinal acetylcholine. They proposed that
glycinergic cells inhibit the cholinergic Starburst amacrine cells and are in turn inhibited by GABA through GABAB receptors.
However, as recently shown, glycinergic cells do not appear to have GABAB receptors. In contrast, the Starburst amacrine cell
has GABAB receptors in a subpopulation of its varicosities. We thus propose an alternate model in which GABAB-receptor
activation reduces the release of ACh from some dendritic compartments onto a glycinergic cell, which then feeds back and
inhibits the Starburst cell. In this model, the GABA necessary to make these receptors active comes from the Starburst cell
itself, making them autoreceptors. Computer simulations of this model show that it accounts quantitatively for the Neal and
Cunningham data. We also argue that GABAB receptors could work to increase the sensitivity to motion over other stimuli.
INTRODUCTION
One of the most important unanswered questions in retinal
neurobiology is why the Starburst cholinergic amacrine cells
have two neurotransmitters (1–4). These cells produce both
acetylcholine (ACh) and g-aminobutyric acid (GABA),
releasing them upon light stimulation (5–9). The released
ACh has many roles in the retina, including the enhance-
ment of motion sensitivity (10–12) and the establishment of
directional selectivity for some types of stimuli (13–20). In
turn, recent evidence shows that GABA is the main trans-
mitter involved in directional selectivity (6,7,21). In this
article, we discuss another possible role suggested by the
cholinergic amacrine cells themselves containing GABAB
receptors (22). Because these receptors often work as auto-
receptors in the brain (23–25), this raises the possibility that
GABA from these cells feeds back onto them to control their
release of ACh. This control could be by hyperpolarization
(26,27), by reducing a Ca21-dependent current (28–30)
through a G-protein mechanism (30–32), or by facilitating a
L-type Ca21 channel (33). The results of Neal and Cun-
ningham (5) coupled to the results of Zucker et al. (22) lend
some support to such an autoreceptor control (see also (34)).
Neal and Cunningham showed that the GABAB agonist
baclofen and the glycinergic antagonist strychnine enhance
the light-evoked release of retinal ACh. Considering these
results, they proposed that glycinergic cells inhibit the
Starburst cells and are in turn inhibited by GABA through
GABAB receptors. However, as shown by Zucker et al. (22),
glycinergic cells do not appear to have GABAB receptors.
Consequently, one must search an alternate hypothesis for
the role of these receptors. The simplest alternative given
the available data is that GABAB agonists enhance the re-
lease of ACh by acting on the Starburst cells themselves.
These cells may synapse onto glycinergic cells (which pro-
bably include the cholinoreceptive DAPI-3 cell (22,35,36)
through muscarinic receptors. (The receptors may be chem-
ically ephaptic, that is, ACh may diffuse to targets far from
the presynaptic site; this would help to explain the apparent
dearth of conventional synapses made by Starburst cells onto
noncholinergic amacrine cells (37)). In addition, retinal
cholinergic receptors are often far away from the site of
cholinergic release (38)—the glycinergic cells of ACh may
provide contact back onto Starburst cells (5,39). Hence, the
activation of GABAB receptors may result in disinhibition.
In this article, we use a biophysical model to test the
feasibility of the GABAB-autoreceptor hypothesis for Star-
burst cells. To know whether this hypothesis will work is not
so easy. One difﬁculty is to know how GABAB agonists
reduce the muscarinic input to the glycinergic cell at the
same time that they increase the overall release of ACh.
Perhaps the answer lies in the recent surprising ﬁnding that
only ;25% of Starburst-cell varicosities contain GABAB
receptors (22). If the input to glycinergic cells came only
from these varicosities, then GABAB agonists might affect
these cells without reducing ACh release from other
varicosities. However, the model must solve another prob-
lem with GABAergic action on Starburst cells. The release of
ACh from Starburst cells may be also inhibited by GABA
through GABAA receptors (8,16,39,40). How is it that the
GABA that putatively feeds back to the GABAB autor-
eceptor does not inhibit the ACh release through the GABAA
heteroreceptor? The model provides answers to these
questions and ﬁts the Neal and Cunningham data well. An
abstract version of the model appeared elsewhere (41).
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The next section of this article will provide the model
assumptions and their justiﬁcations, along with a physical
description of the model. That section will include no
equations to facilitate the comprehension of the ideas. The
model equations and the parameters used in the simulations
will appear in Appendices A and B, respectively.
MODEL
Fig. 1 shows the architecture of the model. We do not intend
it to capture all the known details of the cells. Rather, we
want it to be the simplest model that accounts for the Neal
and Cunningham article (5) and be generally consistent with
the knowledge in the ﬁeld. To start, the model simulations
used only the ON-pathway (42–45), assuming the OFF-
pathway to be similar. Moreover, all model cells except for
the Starburst cell had just one compartment. In turn, the
Starburst cell had ﬁve compartments, a soma, and two
proximal and two distal dendritic compartments. The reason
for having two of each of these compartments was to enforce
morphological symmetry about the soma (44,46).
The reason for having proximal and distal dendritic
compartments in the model was to segregate GABAA and
GABAB receptors. Both these receptors are present in
Starburst cells (8,16,22,39,40), but it is necessary to allow
for the GABA acting on GABAB receptors not to act on
GABAA receptors. If such simultaneous actions were to
occur, then the cell would be shut down by its own GABA.
One can conceive other mechanisms for preventing such
simultaneous actions that do not invoke spatial segregation
of receptors. For instance, GABAA receptors could be
sensitive to GABA at a different range of concentrations than
GABAB receptors. Nevertheless, the assumption of receptor
segregation receives support by the compartmentalization of
GABAB receptors in ;25% of Starburst-cell varicosities
(22). Hence, the relative amount of GABAA and GABAB
receptors is likely to vary across varicosities. Segregation of
GABAergic receptors into different portions of the dendrites
is similar to that proposed for Cl cotransporters in Starburst
cells (21). Furthermore, the inhomogeneity of the GABAB
receptors also resembles that of Kv3 K1 channels in
Starburst cells (47). However, we attach no signiﬁcance to
the proximal versus distal inhomogeneity in the model. No
direct evidence is available for such inhomogeneity, but this
may not be important. We only assume it here for simplicity
and simulations with an inverted disposition of GABAA and
GABAB receptors yield similar results to those in this article.
Because GABAB receptors are proximal in the model, the
synapse to the glycinergic cell must also be proximal. From
the data of Neal and Cunningham (5) and Zucker et al. (22),
we assume that this synapse is muscarinic. (One could also
use nicotinic and GABAA synapses, but this would make the
FIGURE 1 New model for the func-
tion of GABAB receptors in the control
of retinal cholinergic release. In this
ﬁgure, circles, and rounded rectangles
represent somas and dendrites, respec-
tively. The T terminations represent
synapses onto somas and onto den-
drites, with the plus symbol (1) indi-
cating excitatory synapses and the
minus symbol () indicating inhibitory
synapses. The main cell in the model is
the Starburst cell, whose soma is la-
beled SA and which, for simplicity,
contains four dendritic compartments.
Other cells include the bipolar cells
(labeled B) and two types of amacrine
cells (labeled A), one GABAergic and
one glycinergic (labeled Gly). The
direct pathway to the Starburst cell
appears textured, whereas the inhibitory
feedback pathway appears in black.
Bipolar cells making glutamatergic
synapses (labeled Glu) are the begin-
ning of the excitatory pathway. They feed the Starburst cell (synapses labeled 1) and the GABAergic cells (synapses labeled 2). In turn, the GABAergic cells
feed the bipolar inputs (synapses labeled 3) and the distal dendrites of the Starburst cells (synapses labeled 4). The proximal dendrites release ACh, which
excites the glycinergic cell through muscarinic receptors (labeled ACh M and synapses labeled 5). This ACh release that activates muscarinic receptors is
controlled by GABA, which is released from the proximal dendrite and feeds back to it through GABAB receptors (synapses labeled 6). Activation of the
muscarinic receptors on the glycinergic cell causes it to inhibit the Starburst cell (synapses labeled 7). As a result, there is a reduction of cholinergic release from
its distal dendrites. (These dendrites normally feed ganglion cells through nicotinic receptors—labeled ACh N and synapses labeled 8.) If the distal cholinergic
release is much larger than the proximal one, then the model can account for the results of Neal and Cunningham (5). (Evidence suggests that different dendritic
varicosities of the Starburst cell may have different relative amounts of GABAA and GABAB receptors (see Model, in text, for arguments. The division into
proximal and distal dendritic compartments is only for simulation simplicity.)
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model unnecessarily complex.) Furthermore, it is postulated
that GABA is released in a Ca21-independent manner (48–
50) by the proximal dendritic compartment and feeds back
onto it. This assumption is not completely realistic, because
some GABA release from Starburst cells is Ca21 dependent
(51). However, in varicosities with GABAB receptors, their
action suppresses Ca21-dependent release of GABA. Con-
sequently, such a release would only occur early in the
response, that is, before GABAB action begins. Because the
stimulus’ period (333 ms; see Appendix B) is much slower
than most synapses, any Ca21-dependent release would
occur during a negligible portion of the response in the
proximal compartment of the model. Nevertheless, such a
release could happen in the distal compartment, making the
model still compatible with the data of Zheng et al. (51).
Thus, for simplicity, we only included Ca21-independent
release of GABA in the proximal compartment.
The activation of the GABAB autoreceptor would reduce
the gain of the muscarinic synapse by lowering the inﬂux
of Ca21 into the presynaptic site (28–30). Hence, the
glycinergic cell and its synapse would be less active and thus
inhibit less the Starburst cell (Fig. 1). (Alternatively, the
glycinergic cell could inhibit the bipolar-cell input onto
the Starburst amacrine cell (37).) This disinhibition would
increase the release of ACh. How is it possible for the ACh
release to increase at the same time that the muscarinic
synapse is becoming weaker? Again, since GABAB recep-
tors exist only proximally in the model, one can answer this
question if one postulates that there is distal cholinergic
release. What one needs is for the distal release to dominate
the overall release. Therefore, even though the ACh release
that activates muscarinic receptors falls, the total release may
increase. Fortunately, there is evidence that Starburst den-
drites normally release ACh onto ganglion-cells’ nicotinic
receptors (7,52–56).
Bipolar cells making glutamatergic synapses are the
beginning of the model’s excitatory pathway. These cells
receive the visual input (not shown in Fig. 1), and synapse
onto the Starburst and the GABAergic amacrine cells. In
turn, the GABAergic cells feed the bipolar inputs and the
distal dendrites of the Starburst cells. There is evidence for a
GABAergic feedback onto the bipolar cells feeding the
Starburst cell (57). The GABAergic synapse onto the bipolar
cells could be through GABAA (58–61) or GABAC (59,62–
64) receptors. In this article, we will assume for simplicity
that the GABAergic synapses onto bipolar and distal
Starburst dendrites are identical.
METHODS
With one exception, the simulations of the model included only one type of
stimulus: a full-ﬁeld square-wave stimulation whose deﬁnition and param-
eters appear in the Appendices. (The exception appears in the Discussion
and we describe it there.) The computer simulated the response by solving
numerically the system of differential equations representing the model
(Appendix A). This solution used the Dormand-Prince method with adaptive
step size (65) and was implemented in MatLab using Simulink (The
MathWorks, Natick, MA).
All the solutions of the equations used the same parameters, which appear
in Appendix B. With one exception (explained below), we did not attempt to
optimize parameters ﬁnely, but only to capture the data qualitatively. Several
parameters were around values estimated from the literature. We used
parameters as close as possible to the cells of interest, but sometimes, the
only ones we could ﬁnd were not even for the retina. We used them anyway,
as they at least constrained our simulations to realistic values.
Parameters estimated from the literature were as follows: We used a
speciﬁc membrane-capacitance value of 1 mF/cm2. This was close to the
value measured for bipolar, amacrine, and ganglion cells of mudpuppy and
tiger-salamander retinas (66). In turn, for membrane time constants, we used
characteristic vertebrate-neuron values of 10–20 ms (but see (66)). These
values came, for example, from the Guinea-pig’s hippocampal neurons (67),
and from the cat’s spinal motoneurons (68) and sensory-motor-cortex cells
(69). Values for resting potentials were 50 mV, as recorded in the turtle’s
amacrine cells (70). Amacrine-cell soma diameters were between 5 and 10
mm, as in the cat’s AII amacrine cells (71), the primate’s Starburst amacrine
cells (72), and the pigeon’s amacrine cells (73). GABAA and glycinergic
reversal potentials were typical for the retina by being between60 and50
mV. For instance, studies on GABAA and glycinergic synapses were
performed respectively with the turtle’s cone photoreceptors (74) and the
tiger salamander’s amacrine cells (75). In turn, muscarinic receptors
reversed at ;0 mV in most vertebrate tissues. The information on these
receptors came, for example, from the bullfrog’s sympathetic ganglia (76),
the Guinea-pig’s smooth muscles (77), and the bovine ciliary muscle cells
(78). Finally, we set glutamatergic receptors to reverse at 20 mV, as for the
Guinea-pig’s laterodorsal tegmental neurons (79).
Different from these parameters, we had no good experimental basis to
select other synaptic parameters. For instance, maximal synaptic conduc-
tances for our simulations would depend on light-stimulus properties, such
as intensity. Such conductances had not been measured in conditions similar
to those that we were trying to simulate. Hence, we selected these con-
ductances based on the resting conductances of the membrane. The maximal
glutamatergic conductance was the same as the resting conductance of the
cellular compartments. Our rationale was that much smaller glutamatergic
conductances would depolarize the cell too little, whereas much larger ones
would saturate it. Similar considerations were used for the muscarinic con-
ductance. In contrast, the glycinergic conductance was four times stronger
than the resting conductance to produce shunting inhibition (with a similar
rationale applying to the GABAA synapse). We tested the robustness of our
results with these conductance choices by varying each of them individually
by 25% up or down. Our ﬁts remained inside the range of the experimental
values (Figs. 6 and 8) despite these variations.
We only explored the parameter space systematically for slopes and
thresholds of the synapses’ input-output relationships (Eq. A2 in Appendix
A). The exploration was such to ensure that all modeling ﬁts stayed inside
the experimental range (Figs. 6 and 8). Furthermore, best parameters were
those that brought ﬁts as close as possible to the middle of it. For all syn-
apses, except the nicotinic one, we searched for threshold parameters
coarsely, beginning at 50 mV (the cells’ resting potential). We moved
them up and down in units of 10 mV. We also searched for slopes coarsely,
starting at 1 mV1 and moving in units of 0.5 mV1. The only parameters
for which we made an effort to optimize ﬁnely were those of the nicotinic
synapse. This was because it is the main process determining cholinergic
release, the output of the Neal and Cunningham experiments. To optimize
the parameters controlling this release, we ﬁxed all other parameters at their
coarse optimal values and used a Nelder-Mead simplex (direct search)
method (80). After optimization, we tested the robustness of our results by
varying slopes and thresholds individually. Slopes and thresholds were
varied up or down by 0.25 mV1 and 0.5 mV, respectively. The only
exception was the nicotinic slope, which we vary up and down by 0.1 mV1
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(almost a third of the ﬁnal value). Again, our ﬁts remained inside the range of
the experimental values (Figs. 6 and 8) despite these variations.
RESULTS
The simulations in this section are organized according to the
experimental conditions used, ﬁrst considering the control
condition, and then the effects of baclofen, strychnine, and
bicuculline.
Control
The ﬁrst things to consider, in understanding the model’s
behavior, are the potentials in control conditions in the
various compartments. The most-central compartments for
this understanding are those of the Starburst amacrine cell. In
Fig. 2, we show the potentials in this cell’s soma and distal
dendritic compartment (Fig. 1) in response to a full-ﬁeld
square-wave modulation. Appropriately, the response is
periodic. As seen in Fig. 2 A, the response reaches equi-
librium essentially during the ﬁrst cycle. Fig. 2 B shows the
voltage’s details in one of the cycles. Not surprisingly, there
is much voltage attenuation from the distal dendrite to the
soma. In addition, the voltage waveforms are complex, show-
ing two peaks during the cycle. The reason for these peaks
will be understood when we consider the glycinergic input to
the Starburst cell.
From these potentials it is not difﬁcult to understand how
ACh is released. Fig. 3 shows the release from the distal
dendritic compartment (labeled nicotinic in Fig. 3) and from
the proximal dendritic compartment (labeled muscarinic in
Fig. 3) during one cycle of the response. One can see that the
ACh release that activates nicotinic receptors follows the
potential in the distal dendritic compartment of the Starburst
cell. Both this release and the potential have two simulta-
neous peaks. In contrast, the ACh release that activates
muscarinic receptors has only one peak, which temporally
coincides with the ﬁrst peak of the ACh release that activates
nicotinic receptors. The disappearance of the second mus-
carinic peak is due to the activation of the GABAB auto-
receptors,which is local to the proximal dendritic compartment
(Fig. 1). As also seen in Fig. 3, the ACh release that activates
nicotinic receptors is much larger than the ACh release that
activates muscarinic receptors. Consequently, the overall
cholinergic release in the model is dominated by the ACh
release that activates nicotinic receptors. This domination
allows us to explain howACh release that activates muscarinic
receptors can fall under baclofen at the same time that the total
release increases (see Model).
Baclofen
The most important drug used by Neal and Cunningham was
baclofen, an agonist of GABAB receptors; Fig. 4 illustrates its
effects on key potentials and synaptic releases. Inspection of
Fig. 4, A and B, shows that the ﬁrst peak of potential in the
Starburst cell causes simultaneous muscarinic and autore-
ceptor-GABAergic release. (Fig. 4 B shows that the
autoreceptor-GABAergic activation produces a small dip in
the ACh release that activates muscarinic receptors.) Because
of the ACh release that activates muscarinic receptors, the
glycinergic cell responds, albeit with some delay (Fig. 4 A).
The feedback of the glycinergic cell onto the Starburst cell
then causes the complex waveform of the Starburst cell’s
response. The peak of the glycinergic potential coincides with
the valley in the Starburst response, showing that this valley is
FIGURE 2 Somatic and dendritic voltages of the model’s Starburst cell in
control condition. The recorded dendrite is the distal one (top) in Fig. 1. The
stimulus giving rise to these recordings is a 3 Hz full-ﬁeld square-wave
modulation over 2 s with 25% duty-cycle. As seen in panel A, model cells
reach equilibrium essentially during the ﬁrst cycle. Panel B is for the second
cycle of the top graph, but with an expanded timescale. One can see that the
depolarization is attenuated from the dendrite to the soma and that the
waveforms are complex, having two peaks during the cycle.
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due to the glycinergic feedback. As the glycinergic activity
falls, the Starburst potential rises again, generating the second
peak. This peak is smaller than the ﬁrst peak because of the
glycinergic inhibition. This peak’s smallness, coupled to the
autoreceptor inhibition, essentially prevents further ACh
release that activates muscarinic receptors. When one adds
baclofen (Fig. 4, C and D), dramatic effects occur both in the
potentials and in the transmitter releases. Baclofen boosts the
GABAB activity so much that all ACh release that activates
muscarinic receptors is canceled (Fig. 4D). As a result of this
cancellation, the glycinergic potential does not rise, causing
the Starburst potential to be larger and unimodal (Fig. 4 C).
Strychnine
In many respects, strychnine, a glycinergic antagonist, mimics
the effects of baclofen, because both drugs reduce the output of
the glycinergic synapse. Fig. 5 illustrates the similarity of the
effects. Fig. 5 A of this ﬁgure is identical to that in Fig. 4 A, but
Fig. 5 B shows total cholinergic release instead of just ACh
release that activates muscarinic receptors. Not surprisingly,
both cholinergic and glycinergic releases follow the potentials
at the Starburst and glycinergic cells, respectively. When one
adds strychnine (Fig. 5,C andD), the cholinergic release (Fig. 5
D) becomes more potent and longer lasting (the two peaks
merge). This is because there is no glycinergic inhibition of the
cholinergic cell. Curiously though, this does not mean that
glycinergic release is over and inspection of Fig. 5D shows that
this release is also boosted. What is absent is the activation of
glycinergic receptors on the Starburst cell. Because of the lack
of this activation, the Starburst potential is larger and longer
(Fig. 5C), causing more ACh release that activates muscarinic
receptors and thus, larger glycinergic potential (Fig. 5 C).
These results with baclofen and strychnine are consistent
with Neal and Cunningham’s Figs. 1–3 and their Fig. 5.
Moreover, the muscarinic control of glycinergic release in
the model is consistent with their Fig. 6. As our Fig. 6 shows,
although the model is simplistic in details, it ﬁts these data
quantitatively (ﬁrst four columns in our Fig. 6). These ﬁts
include data on background as well as light-evoked release
of ACh. And the model also ﬁts the data when one combines
baclofen and strychnine (ﬁfth column in our Fig. 6). Using
this combination of drugs yields the same increase in
cholinergic release as when each drug is used in isolation
(second and fourth columns). This should not be surprising,
as the main effect of both these drugs is to kill glycinergic
action on the Starburst cell.
Bicuculline
Neal and Cunningham also used bicuculline, a GABAA
antagonist, in addition to baclofen and strychnine. Fig. 7
shows how the model reacts to bicuculline and to its
combination with baclofen. Bicuculline causes a relatively
small increase in the Starburst potential without eliminating
its two peaks (Fig. 7 A). This increase follows an increase
in the bipolar input to the Starburst cell. Furthermore, the
increase in Starburst potential follows a reduction of the
inhibition in this cell’s distal dendritic compartment (Fig. 1).
As a result of this increase in potential, the cholinergic
release also undergoes a small augmentation (Fig. 7 B). The
increase in potential is much more dramatic when one adds
baclofen to the bicuculline (Fig. 7 A). Comparison of Figs. 4
and 7 reveals that the combination of bicuculline and bac-
lofen causes a larger increase in potential than with each drug
in isolation. This dramatically increased potential leads to a
boosted release of ACh (though the boost seems to be in the
duration of the release and not in its total amplitude).
As for baclofen and strychnine, the results with bicucul-
line are also consistent with Neal and Cunningham’s data
(see their Fig. 4). And the model again provides a quan-
titatively good ﬁt to the data as shown in our Fig. 8. The ﬁt
applies to bicuculline’s effect on background and on light-
evoked release of ACh. In addition, the ﬁt applies to the
simultaneous effect of bicuculline and baclofen.
DISCUSSION
We model the circuit linking Starburst and glycinergic
amacrine cells, and account for a host of pharmacological con-
ditions (5). The model postulates that GABAB receptors on the
Starburst cell function as autoreceptors, whose role is to con-
trol the cholinergic contact onto glycinergic cells. In turn, these
cells feed-back onto the Starburst cell, inhibiting it with gly-
cine. This feedback loop is sufﬁcient to account quantitatively
FIGURE 3 Cholinergic release in control condition in the model. The
release is shown for the synapses 5 (here labeled muscarinic) and 8 (here
labeled nicotinic) of Fig. 1. We are normalizing the individual releases by
the maximum of their sum and the period of the release is the same as in Fig.
2 B. The ACh release that activates nicotinic receptors is much larger than its
muscarinic counterpart. The nonzero release between 0.46 and 0.66 s reﬂects
the tonic cholinergic release without light stimuli.
Starburst GABAB Receptors 477
Biophysical Journal 91(2) 473–486
for the increased release of ACh under baclofen and strychnine
(Figs. 4–6). Moreover, this loop can explain the reduced
glycinergic release by baclofen (Fig. 4) and the effect of
muscarinic drugs on this release (Fig. 1). Effects involving
GABAA antagonists are accounted for, too (Figs. 7 and 8).
Limitations of the model
The main limitations of the model are due to the simplicity of
its components. Perhaps its main simplifying feature is its
segregation of GABAergic receptors, and of ACh release
that activates nicotinic and muscarinic receptors into differ-
ent dendritic compartments of the Starburst cell. We already
discussed the rationale and limitations of this segregation
assumption in Model. In Experimental Predictions, we will
address some of the consequences of segregation.
To make the model more realistic, one would have to
include better morphological structure for all cells (Fig. 1). In
addition, one would have to use synaptic mechanisms and
inputs to bipolar cells that are more realistic (Appendix A). A
beneﬁt of using realistic morphology for the Starburst cell
would have been an assessment of the spatial-separation
requirements for this cell’s synaptic inputs and outputs. The
details of this cell’s response dynamics would also change,
but we do not believe that the main conclusions would
be modiﬁed (Model). The synapses are modeled without
dynamics—that is, assuming that they are sufﬁciently fast
to be in quasi steady state. This is probably true, since the
FIGURE 4 Effect of baclofen in the model. This effect is shown for the voltages at the glycinergic cell and at the distal dendrite of the Starburst cell (A and
C). Moreover, the ﬁgure displays the effect for transmitter release at the Starburst cell’s muscarinic (synapses labeled 5 in Fig. 1) and GABAB (synapses labeled
6 in Fig. 1) synapses (B and D). We show these voltages and releases over the same period as in Fig. 2 B. At each synapse, the plots normalize release to the
maximum release in control condition. Panel A shows that the two control-voltage peaks result from the rise of glycinergic activity exactly at the minimum
between the peaks. Baclofen eliminates the glycinergic activity, destroying the two peaks and increasing depolarization in the Starburst cell (C). This
elimination of glycinergic activity is due to the blockade of ACh release that activates muscarinic receptors by baclofen (D). Baclofen’s induced increase in
depolarization causes several processes to increase in amplitude, including the release at the GABAB synapse. This synapse’s role can be appreciated in control
conditions when its maximal release coincides with a small local minimum at the ACh release that activates muscarinic receptors (B).
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stimulus’ period (333 ms; see Appendix B) is much slower
than most synapses. However, this may not apply to the
GABAB synapse, since it may depend on a G-Protein second-
messenger pathway (30–32). If we were to slow down this
synapse in the model, the dynamics of the responses would
change and the autoreceptor control may lose its effective-
ness at high temporal frequencies. The stimulus’ slowness is
also our justiﬁcation for disregarding the dynamics of the
input to the bipolar cell (Appendix A). However, it would
have been better not to neglect these dynamics if we wanted
to predict the results of faster experiments. Moreover, the
model input to the bipolar cell neglected surround-inhibition
from horizontal cells. This hampers the ability to make
predictions on the effect of spatial frequency. If spatial fre-
quency were of interest, then one would have to include
a richer spatial representation of the inputs. Because the
stimuli are full-ﬁeld square-waves (Methods), there is no
need to worry about spatial frequency. For these stimuli,
surround-inhibition only reduces the bipolar-cell gain.
Functional roles
The roles of several components of the model have been
discussed elsewhere. For instance, the role of the GABAer-
gic input to the bipolar cells may be to give the retina
a degree of transience (81–83). In turn, one role of the
GABAergic input to the distal dendrites of the Starburst cell
may be to contribute to directional selectivity ((16,84); but
see (85)). What could be the role of the GABAB-controlled
glycinergic feedback loop to the Starburst cell? We propose
that this loop could work to make the sensitivity of ACh
release in response to motion larger than those in response
to other stimuli. Acetylcholine has been proposed to be
involved in the enhancement of retinal motion sensitivity
FIGURE 5 Effect of strychnine in the model. This effect is shown for the same variables as in Fig. 4, except that the releases are of ACh (sum of synapses
labeled 5 and 8 in Fig. 1) and glycine (synapses labeled 7 in Fig. 1). (A–D) Plotting conventions, and periods are also as in Fig. 4. This ﬁgure conﬁrms and
extends the conclusion of Fig. 4 that the two control-voltage peaks result from the rise of glycinergic activity exactly at the minimum between the peaks (A).
Strychnine does not eliminate glycinergic release (D), but eliminates its postsynaptic action. As a result, strychnine destroys the two peaks and increases the
depolarization in the Starburst and glycinergic cells (C). Therefore, ACh and glycine releases also increase (B and D).
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(10–12) and in preferred-direction facilitation in direction-
ally selective cells (10,86,87). Here is how we think of the
GABAB-receptor involvement in these motion functions. If
one suddenly delivers a no-motion stimulus to the Starburst
cell, then the GABAB action on the muscarinic synapse may
not have time to react. This is because a slow G-protein
second-messenger system may mediate this action (30–32).
Without this action, muscarinic activation of the glycinergic
cell can occur and thus, there is inhibitory feedback onto the
Starburst cell (Fig. 1). If instead of sudden stimuli, a suf-
ﬁciently slow motion sweeps through the Starburst cell, then
a different set of events take place. Consider a motion
sweeping from left to right in Fig. 1. The left bipolar cells
will be the ﬁrst to be made active, depolarizing the Starburst
cell. This depolarization would start the GABAB loops
(synapses labeled 6 in Fig. 1) even before the motion reaches
the right bipolar cells. In this case, when the motion ﬁnally
reaches them, the ACh release that activates muscarinic
receptors to the glycinergic cell is truncated, eliminating the
glycinergic feedback onto the Starburst cell.
To illustrate these predictions of the model, we added an
artiﬁcial constant delay to the GABAB synapse (Eq. A4 in
Appendix A). Furthermore, we activated the bipolar cells
sequentially to simulate motion. These cells were still activated
by a 3-Hz square-wave (Eq. A1). However, the cycle of any
given bipolar cell started after that of the neighbor to its left
by a preset delay. For example, in Fig. 9 A, this delay was
100 ms, implying an edge motion sweeping the Starburst cell
in 400 ms from left to right. The ﬁgure shows the response as
recorded on the right distal dendritic compartment. As
predicted, the response to the motion was larger than the
response to the full-ﬁeld stimulation (Fig. 9 A). With this
delay and this motion, the facilitation of the amplitude of
response above resting potential was 84.1%. Without the
GABAB delay, facilitation disappeared (only 7.6% for this
motion and negative for other motions). However, although
the GABAB delay had effects on the details of the responses,
it did not affect the qualitative effects of the various
pharmacological drugs described earlier in the article. Even
FIGURE 7 Effect of bicuculline and baclofen in the model. To illustrate
this effect, we use the voltage at the distal dendrite of the Starburst cell (A).
Furthermore, the ﬁgure displays the effect for cholinergic release from this cell
(sum of Synapses 5 and 8 in Fig. 1). (B) The display conventions and periods
are as in Fig. 4. In this ﬁgure, the curve Bic1Bac corresponds to the condition
where bicuculline and baclofen are both applied. Bicuculline increases the
depolarization of the Starburst cell and thus the cholinergic release. Adding
baclofen to bicuculline causes further depolarization and cholinergic release,
though the latter rises mostly due to the prolongation of the response.
FIGURE 6 Comparison between experiments and model on the effects of
baclofen and strychnine. The experimental data are total ACh releases taken
from Neal and Cunningham (5). These data appear either as standard-error
bars (if provided by the authors), or as ranges (given by the lower and higher
white squares) and medians (given by the middle square). The categories in
the data’s horizontal axes are as follows: Light/Back is the ratio between light-
evoked and spontaneous releases in control condition. Bacl / Back and
Stryc / Back are the post- to pre-drug ratios of spontaneous release for
baclofen and strychnine, respectively. Bacl/ Light and Stryc/ Light are
the post- to pre-drug ratios of light-evoked release for baclofen and
strychnine, respectively. B1S/ Light is the same, but for using baclofen
and strychnine simultaneously. The model values fall within the experimental
ranges and error estimates for all control, baclofen, and strychnine conditions.
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with this delay, baclofen and strychnine still increased the
response (compare Fig. 9 B with the solid line of Fig. 9 A).
Bicuculline alone did not have a major effect on the re-
sponse (compare Fig. 9, A and B). But bicuculline aug-
mented the effect of baclofen (Fig. 9 B). These results with
baclofen, strychnine, and bicuculline were similar to those in
Figs. 4–8.
Hence, the model predicts that the Starburst cell’s
responses and release of ACh may be larger for motion
than for other stimuli. In the example above, the enhance-
ment of the responses to motion is particularly relevant for
the right dendrites. This is because the left dendrites may be
inhibited by GABAA mechanisms. If the right dendrites
make preferential synapses onto directionally selective cells
with rightward preferred-direction (16,17), then GABAB
receptors may be crucial for preferred-direction facilitation in
these cells. The same would hold for directionally selective
cells with different preferred directions.
Experimental predictions
One novel aspect of the model is the proposal that GABAB
receptors work as autoreceptors in the Starburst cell. There
are many experiments in the literature trying to prove that
particular receptors work as autoreceptors (23–25). For the
most part, these experiments try to investigate whether a cell
containing a particular transmitter responds to that transmit-
ter. It is known that Starburst cells respond to GABA, but no
current or voltage responses to baclofen have been observed
(39). However, we propose that baclofen has an effect on the
muscarinic synapse without affecting particular conduc-
tances. An ideal experiment would measure baclofen’s effect
on ACh’s release from Starburst cells synaptically isolated
from the rest of the retina. One could attempt to isolate
the Starburst cells synaptically by using low-Ca21 media.
Unfortunately, this condition would also shut down these
cells’ synapses, eliminating ACh release. Alternatively, one
could use a cell culture to try to isolate the cholinergic
Starburst cell. An experiment that is more feasible is to
study whether the effect of baclofen on cholinergic and
glycinergic releases is interrupted by drugs that interfere with
G-protein pathways. This would not prove the existence of
FIGURE 9 Effect of adding a constant delay to the GABAB synapse. We
illustrate this effect by showing voltage at the right distal dendrite as in Fig. 2
B. Here, we show the results for a 50-ms delay. In panel A, we activate the
bipolar cells sequentially to simulate motion. These cells are still activated
by a 3-Hz square-wave (Eq. A1). However, the cycle of any given bipolar
cell starts after that of the neighbor to its left by a preset delay. In this ﬁgure,
this delay is 100 ms, implying an edge motion sweeping the Starburst cell in
400 ms from left to right. As predicted, the response to the motion is larger
than the response to the full-ﬁeld stimulation. In contrast, without the
GABAB delay, motion facilitation over the full-ﬁeld responses disappeared
(see text for details). In panel B, we use full-ﬁeld stimulation, with different
combinations of drugs. The curves for baclofen and strychnine superimpose.
Comparison of these curves with those in panel A reveals that even with the
delay, these drugs augment the response. In turn, bicuculline on its own has
little effect, but increases the effect of baclofen on the response (Bic1Bac),
as in Figs. 7 and 8.
FIGURE 8 Comparison between experiments and model on the effects of
bicuculline and baclofen. The data’s source and ﬁgure’s conventions are as
in Fig. 6. The categories in the data’s horizontal axes are as follows: Bic/
Back and Bic/ Light are the post- to pre-drug ratios of spontaneous and
light-evoked releases, respectively, for bicuculline. B1B / Light is the
post- to pre-drug ratio of light-evoked releases for baclofen starting from a
bicuculline condition. Again, the model values fall within the experimental
ranges and error estimates for all bicuculline and baclofen conditions.
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autoreceptors, but would provide circumstantial evidence for
them as they tend to work through such proteins (30–32).
Another novel aspect of the model is that different types of
GABAergic receptors may have different distributions
across the Starburst cell’s dendritic tree. Indirect evidence
is now available for such different distributions of receptors
(see Model for detailed arguments). The same differences
should apply for cholinergic synapses. A test for such
different distributions would be to use antibodies against
these receptors and synapses in an identiﬁed Starburst cell.
One could then check microscopically whether there are
different distributions of immunoreactivity with the different
antibodies. If such differences exist, then they would raise
the possibility that the Starburst dendrite has more function-
ality than previously thought. Some studies propose that this
cell’s dendritic branches may function as independent elec-
trotonic subunits (16,84,85,88). If different receptors and
synapses have different distributions in the dendritic tree,
then this may allow different portions of a dendritic branch to
have different roles in information processing.
APPENDIX A: EQUATIONS
This Appendix presents all the equations used to simulate the model in Fig. 1.
Light stimuli
With the exception of the motion described in the Discussion, the light
stimuli used in the simulations paralleled those used by Neal and Cun-
ningham (5). Here, we will discuss the model only in the context of their
stimuli. We used full-ﬁeld square-wave stimulation,
SðtÞ ¼ a if
n
f
# t,
n1 d
f
; n ¼ 0; 1; 2; . . .
0 otherwise
;
8<
: (1)
where a, f, and d are the amplitude, frequency, and duty-cycle of the wave,
respectively.
Biophysical notation
Because the stimulus is full ﬁeld, all the bipolar compartments in Fig.
1 respond alike. The same holds for the GABAergic compartments,
glycinergic compartments, the two proximal dendritic compartments of the
Starburst cell, and its two distal compartments. In this Appendix, we will
denote a compartment by the subindex c. This subindex can attain the values
of b, g, g, s, p, and d for the bipolar, GABAergic, and glycinergic cells, soma
of the Starburst cell, and its proximal and distal compartments, respectively.
(Although the simulations do not include the ganglion cell, its subindex will
be gc for simplifying the notation below.) Besides cells and compartments,
release of neurotransmitters is identical for several different synapses
containing the same transmitter. We will denote a neurotransmitter by the
subindex n. This subindex can attain the values of gu for glutamate, ga for
GABA released from GABAergic cells toward GABAA receptors, gy for
glycine, gb for GABA released onto GABAB autoreceptors, and mu and ni
for ACh released onto muscarinic and nicotinic receptors, respectively.
This article models the cellular compartments through standard cable-
theory assumptions (89). The most important variable in this model is the
compartment’s potential (voltage), Vc(t). A compartment’s potential causes
transmitter release, which is denoted by Rc1 ;n;c2 ðtÞ, with c1 and c2 being the
pre- and postsynaptic compartments, respectively. For instance, Rp, mu, g is
the ACh release that activates muscarinic receptors from the proximal
dendritic compartment of the Starburst cell onto the glycinergic cell. In turn,
neurotransmitter release causes the activation of a membranous postsynaptic
conductance, whose symbol is gc1 ;n;c2 ðtÞ. Besides synaptic conductances,
between any two neighbor compartments of the Starburst cell, there is an
axial conductance gc1;ax;c2 . And all the model’s compartments also have
resting conductances, which we denote gc, r, c.
We denote by Ix,y,c the current ﬂowing through the conductance gx,y,c into
compartment c. To calculate this current, one needs the compartment’s
voltage (Vc(t)) and the conductance’s reversal potential, Ey,c. The axial-
conductance current ﬂowing from compartment c1 to compartment c is
Ic1;ax;c. From the axial and membranous currents, one can calculate the
temporal evolution of the voltage at the compartment if one has its
capacitance Cc. This capacitance and resting conductance were computed
from the multiplication of the compartment’s membranous area (Ac) by their
speciﬁc values, denoted Cˆ and gˆr;c, respectively.
Synapses
All synapses in the model, except for the GABAB synapse, respond
conventionally to presynaptic voltage. We model conventional synapses as
if they are not the temporal bottlenecks of the system. The sigmoidal pre-
synaptic-to-transmitter relationship in the model conventional synapses
follows the steady-state input-output curves found experimentally (90,91).
This relationship is
Rc1;n;c2ðtÞ ¼
bn;c2
11 expðanðVcðtÞ  unÞÞ; (2)
where bn;c2.0 is the synapse’s gain, an . 0 is the slope of the synapse’s
input-output relationship, and un is the synaptic threshold. Without loss of
generality, one can set the post-synaptic conductance equals to release, since
bn;c2 could be made to have units of conductance:
gc1 ;n;c2ðtÞ ¼ Rc1 ;n;c2ðtÞ: (3)
In Appendix B we express bn;c2 with such units.
The GABAB synapse responds differently to presynaptic voltage than
conventional synapses, since this synapse does not induce, directly, a
conductance change (see Model). Instead, this synapse reduces the
presynaptic Ca21 conductance in the muscarinic synapse to the glycinergic
cell. As a result, this synapse’s gain falls. We model this fall by letting bmu, g
depend on the locally released GABA,
bmu;gðtÞ ¼
bˆmu;g
11Rp;gb;pðtÞ; (4)
where bˆmu;g.0 is the gain of the muscarinic synapse when the GABAB
receptors are not activated. (This equation assumes that the Starburst-cell
release of GABA has the same dependence on presynaptic voltage as other
releases (i.e., Eq. 2). This assumption cannot be, strictly speaking, correct.
This is because we assume that this release is Ca21 independent and thus not
affected by the activation of the autoreceptors. The use of Eq. A2 is only
justiﬁed for the sake of model simplicity, since there are no good models of
Ca21-independent release.) Such a model must be taken as a simple
abstraction of the complicated G-protein-dependent mechanism by which
the GABAB autoreceptors work (30–32). A complete model would have to
include the complete G-protein pathway.
Currents and potentials
This section describes how we calculate the voltages across the membranes
of the different cellular compartments. This calculation is identical in all
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compartments except for the bipolar cells. The currents ﬂowing through
synaptic or resting conductances depend on the voltage at nonbipolar com-
partments and on the conductances’ reversal potentials. These currents are
Ix;y;cðtÞ ¼ gx;y;cðtÞðEy;c  VcðtÞÞ: (5)
The current ﬂowing into compartment c from a compartment c1 through an
axial conductance is
Ic1 ;ax;cðtÞ ¼ gc1;ax;cðtÞðVc1ðtÞ  VcðtÞÞ: (6)
From these currents, the potential in the nonbipolar compartment follows
Cc
dVcðtÞ
dt
¼ +
Nc
i¼1
Ixi ;yi ;cðtÞ; (7)
where Nc is the number of types of currents ﬂowing into compartment c.
The bipolar cells are special cases among all compartments, because one
of its inputs does not come from synapses but directly from light. We model
this input as a current being injected onto the bipolar compartment. In
addition, this compartment receives a GABAergic current and has a resting-
conductance current (Fig. 1), making Nb ¼ 3 in Eq. A7. For simplicity, the
stimulus current is exactly S(t) (Eq. A1). This means that the simulations
neglect the temporal properties of the photoreceptors feeding the bipolar
cells, that is, they consider the input’s dynamic sufﬁciently slow. For the
same reason, the simulations assume that the bipolar compartment has zero
capacitance, that is, Cb ¼ 0. With these assumptions, one can set the left-
hand side of Eq. A7 to 0 and use Eq. A5 to get
VbðtÞ ¼ SðtÞ1 gb;r;bEr;b1 gg;ga;bðtÞEga;b
gb;r;b1 gg;ga;bðtÞ ;
where gg, ga, b(t) obeys Eq. 3. This voltage is then fed to the bipolar synapse,
whose glutamatergic release is governed by Eq. 2.
APPENDIX B: PARAMETERS
This Appendix presents the simulation parameters, with the notation of
Appendix A, and organized in four sets: stimulus, synaptic, cellular, and
pharmacology.
Stimulus parameters
The three parameters of the stimulus (Eq. 1) were a ¼ 8 pA, f ¼ 3 Hz, and
d ¼ 0.25.
Synaptic parameters
We present the synaptic parameters (Eqs. 2–5) in six subsets: glutamatergic,
GABAA, glycinergic, GABAB, muscarinic, and nicotinic synapses.
Glutamatergic synapses
agu ¼ 0:5mV1; ugu ¼ 40mV; bgu; g ¼ bgu; s ¼ bgu; p
¼ bgu; d ¼ 50 pS; Egu; g ¼ Egu; s ¼ Egu; p ¼ Egu; d ¼ 20mV:
GABAA synapses
aga ¼ 1mV1; uga ¼ 50mV; bga; b ¼ 200 pS;
bga; d ¼ 25 pS; Ega; b ¼ 50mV; Ega; d ¼ 60mV:
Glycinergic synapses
agy ¼ 1mV1; ugy ¼ 40mV; bgy; s ¼ bgy; p ¼ bgy; d ¼ 250
pS; Egy; s ¼ Egy; p ¼ Egy; d ¼ 60mV:
GABAB synapses
agb ¼ 1mV1; ugb ¼ 40mV; bgb; p ¼ 25 pS:
Muscarinic synapses
amu ¼ 10mV1; umu ¼ 40mV;
bˆmu;g ¼ 250 pS; Emu; g ¼ 0mV:
Nicotinic synapses
ani ¼ 0:312mV1; uni ¼ 46mV; bni; gc ¼ 250 pS:
The only exception is that bˆmu;g ¼ 125 pS for the central glycinergic cell, so
its total muscarinic input is equal to the other glycinergic cells in the full-
ﬁeld experiments.
Cellular parameters
Three cellular parameters (Eqs. 5–7) were identical for all compartments: the
speciﬁc membrane capacitance (Cˆ ¼ 1mF/cm2), the resting potential (Er, c¼
–50 mV), and the axial conductance (gc1 ;ax;c2 ¼ 50 pS). The rest of
parameters are organized in two sets: compartmental membranous areas and
speciﬁc resting conductances.
Compartmental membranous areas
Ab ¼ Ag ¼ As ¼ 1000mm2; Ag ¼ Ap ¼ Ad ¼ 250mm2:
Speciﬁc resting conductances
gˆr;b¼ gˆr;g¼ gˆr;s¼ gˆr;p ¼ gˆr;d ¼ 20mS=cm2; gˆr;g ¼ 10mS=cm2:
Pharmacology parameters
The simulations of the pharmacology were performed by setting the
appropriate parameters to zero when a particular drug was used. We present
the pharmacology parameters in three subsets: baclofen, strychnine, and
bicuculline.
Baclofen
bˆmu;g ¼ 0:
Strychnine
bgy; s ¼ bgy; p ¼ bgy; d ¼ 0:
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Bicuculline
bga; d ¼ 0:
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